Home /
Litfulo: European Agency strengthens warnings on alopecia treatment The European Medicines Agency warns of psychiatric and neurological risks linked to Litfulo .
Published 7sem · 1 source Notable · updated 5sem
The fact This treatment for severe alopecia has been prescribed in the US and Europe since 2023 .
Health authorities recommend increased monitoring of patients using this drug.
🔗 Click the link to read an article on the topic:
Why it matters Le Litfulo est un traitement récent contre l’alopécie, une affection touchant des millions de personnes. Les nouvelles alertes de l’EMA pourraient influencer les prescriptions et la confiance des patients dans ce médicament.
What if you saw the whole news differently? Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page. → États-Unis · © OpenStreetMap, OpenMapTiles, OpenFreeMap World map → Auto-synthesis from 1 media source · identified on July 22, 2026